SEC Filings TLDR

This Amendment No. 6 to Schedule 13D, filed by Vorini Holdings Inc. and other reporting persons, updates the ownership details of Safe Bulkers, Inc. common stock. As of October 14, 2025, the reporting persons collectively own 51,576,425 shares, representing approximately 50.41% of the outstanding shares. The amendment ...

Bin Zhou, the reporting person, filed Amendment No. 7 to Schedule 13D for Planet Green Holdings Corp. The amendment updates the ownership details and transactions involving the company's common stock. Zhou has acquired shares through various share purchase agreements, with the most recent transaction on December 7, 202...

Shah Capital Management, a significant shareholder of Novavax, Inc., has filed an amendment to its Schedule 13D, urging the company's board of directors to undertake a formal strategic review, including a potential sale of the company. Shah Capital, which owns 7.2% of Novavax's common stock, expressed concerns over the...

GAMCO Investors, Inc. and its affiliates have filed a Schedule 13D/A amendment, disclosing an increased ownership of 5.4% in Lennar Corp's Class B Common Stock. The filing details the acquisition of 1,720,157 shares, valued at approximately $210.25 million. The transaction was executed through various investment vehicl...

This Amendment No. 1 to Schedule 13D, filed by Cooperatieve Gilde Healthcare IV U.A. and related entities, reports the sale of 174,678 common shares of LAVA Therapeutics N.V. between October 8, 2025, and October 13, 2025. The shares were sold in open market transactions at weighted average prices ranging from $1.5377 t...

Blue Owl Capital Holdings LP has filed an amendment to its Schedule 13D, reporting an increased beneficial ownership in Katapult Holdings, Inc. The filing indicates that Blue Owl Capital Holdings LP now owns 38.58% of Katapult's common stock, up from a previous undisclosed percentage. The increase is attributed to chan...

This Amendment No. 7 to the Schedule 13D filed by the Reporting Persons on November 28, 2022, relates to the Common Stock of Grindr Inc. The amendment discloses that the Reporting Persons, along with George Raymond Zage III and related entities, are exploring the possibility of acquiring Grindr in a going private trans...

This Amendment No. 6 to the Schedule 13D filed by the Reporting Persons on November 28, 2022, relates to the Common Stock of Grindr Inc. The amendment discloses the acquisition of 1,000,000 shares of Common Stock by Mr. Zage from Longview Grindr Holdings Limited using personal funds. The Reporting Persons, along with J...

Franklin Resources Inc. (FRI) has filed a Schedule 13D/A amendment reporting a 30.5% ownership in Clarion Partners Real Estate Income Fund Inc. The filing details that FRI, along with its investment management subsidiaries, holds 24,764,871 Class I Shares of Common Stock. The shares were acquired for investment purpose...

ESSA Pharma Inc. was acquired by Xeno Acquisition Corp. on October 9, 2025, through an arrangement under Section 288 of the Business Corporations Act (British Columbia). The acquisition involved XenoTherapeutics, Inc., XOMA Royalty Corporation, and a wholly-owned subsidiary of XenoTherapeutics, Inc. The transaction res...

Situational Awareness LP, along with its affiliates SAF AI GP LP, Situational Awareness LLC, Situational Awareness Partners LP, Leopold Aschenbrenner, and Carl Shulman, have filed an amended Schedule 13D to report their increased ownership in Core Scientific, Inc. The reporting persons collectively own 28,756,478 share...

This Amendment No. 3 to Schedule 13D, filed by Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Harwin, and Tomas Kiselak, reports the entry into a lock-up agreement with Apogee Therapeutics, Inc. in connection with the company's underwritten public offering. The lock-up agreement restricts the ...

Reprogrammed Interchange LLC and Reid Hoffman filed Amendment No. 6 to Schedule 13D, reporting changes in their ownership of Vor Biopharma Inc. common stock. The amendment details transactions from October 8, 2025, through October 9, 2025, where Reprogrammed Interchange LLC sold shares in open market transactions, resu...

This Amendment No. 2 to Schedule 13D, filed by Abundant Grace Investment Limited, NBNW Investment Limited, and Bin Li, updates the ownership details of Class A ordinary shares of Uxin Limited. The filing discloses that Grace directly holds 18,830,582,710 Class A Ordinary Shares, with NBNW holding 68.6% of Grace's votin...

Amendment No. 5 to Schedule 13D for ReNew Energy Global plc, filed on October 10, 2025, discloses a revised non-binding proposal by a consortium including Canada Pension Plan Investment Board, Platinum Hawk C 2019 RSC Limited, Abu Dhabi Future Energy Company PJSC-Masdar, and Sumant Sinha. The consortium proposes to acq...

The filing is an Amendment No. 4 to the Schedule 13D submitted by the Reporting Persons, including Abu Dhabi Investment Authority, Platinum Cactus A 2019 Trust, and Platinum Hawk C 2019 RSC Limited, regarding their ownership of Class A Ordinary Shares of ReNew Energy Global plc. The amendment includes a revised non-bin...

Canada Pension Plan Investment Board, along with other consortium members, has submitted a revised non-binding proposal to acquire all outstanding Class A ordinary shares of ReNew Energy Global plc at $8.15 per share. This proposal represents a 29% premium to the closing share price on December 10, 2024, and a 41% prem...

This Amendment No. 2 to Schedule 13D, filed by Daniel Wagner, the Estate of John Wagner, and DBLP Sea Cow Limited, reports the sale of 10,600,000 ordinary shares of Rezolve AI plc by DBLP in an open market transaction at $5.40 per share. The filing provides updates on the beneficial ownership of the shares, detailing t...

PAVmed Inc. filed an amendment to its Schedule 13D regarding its ownership of Lucid Diagnostics Inc. common stock. The amendment discloses that PAVmed Inc. holds 38,816,903 shares, representing 28.3% of the outstanding common stock. The filing also details the voting and dispositive power of the reporting person and it...

This filing is Amendment No. 18 to the Schedule 13D originally filed on July 1, 2025, by Vladimir Galkin and Angelica Galkin regarding their beneficial ownership of shares in Newegg Commerce, Inc. The amendment updates their ownership details, reflecting that they jointly own 3,888,888 shares of Common Stock, represent...

PAVmed Inc. filed an amendment to its Schedule 13D regarding its ownership of Lucid Diagnostics Inc. common stock. The amendment updates the reporting person's ownership details, including the number of shares held and voting power. PAVmed Inc. holds 38,816,903 shares, representing 28.3% of the outstanding common stock...

Imperial Petroleum Inc. filed Amendment No. 6 to Schedule 13D regarding its ownership of common stock in C3is Inc. The amendment updates the number of shares beneficially owned by Imperial Petroleum due to changes in the conversion price of the Series A Convertible Preferred Stock, adjusted to $2.50 following a registe...

Imperial Petroleum Inc. has filed Amendment No. 6 to Schedule 13D regarding its ownership of common stock in C3is Inc. The amendment updates the number of shares beneficially owned by Imperial Petroleum due to changes in the conversion price of the Series A Convertible Preferred Stock, adjusted to $2.50 following a reg...

This Amendment No. 4 to Schedule 13D, filed by Flawless Management Inc., Arethusa Properties LTD, and Harry N. Vafias, updates the beneficial ownership of C3IS Inc.'s common stock. The amendment reflects changes due to the issuance of shares and the exercise of warrants, resulting in the Reporting Persons no longer own...

This Amendment No. 3 to Schedule 13D, filed on October 10, 2025, pertains to the Common Stock of Biomea Fusion, Inc. The filing is made by Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asse...